Portinari: A Data Exploration Tool to Personalize Cervical Cancer Screening
|
|
- Phillip Wilkinson
- 6 years ago
- Views:
Transcription
1 Portinari: A Data Exploration Tool to Personalize Cervical Cancer Screening Sagar Sen, Manoel Horta Ribeiro, Raquel C. de Melo Minardi, Wagner Meira Jr., Mari Nygård Certus V&V Center and HPV Research Group, Department of Computer Science, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, HPV Research Group, Cancer Registry of Norway, Oslo, Norway 1
2 Software s Impact in Societal Processes Through which means societies organize themselves? 2
3 Software s Impact in Societal Processes Through which means societies organize themselves? politics 2
4 Software s Impact in Societal Processes Through which means societies organize themselves? politics 2
5 Software s Impact in Societal Processes Through which means societies organize themselves? politics social bonds 2
6 Software s Impact in Societal Processes Through which means societies organize themselves? politics social bonds 2
7 Software s Impact in Societal Processes Through which means societies organize themselves? politics social bonds labour 2
8 Software s Impact in Societal Processes Through which means societies organize themselves? politics social bonds labour 2
9 Self-organizing vs. Centralized 3
10 Self-organizing vs. Centralized 3
11 Self-organizing vs. Centralized vs 3
12 Self-organizing vs. Centralized vs 3
13 4
14 Norway s Screening Program AGUS/ASC-H/HSIL/ACIS/Ca Immediately Colposcopy with biopsy Entry intro screening program years of age Unsatisfactory 1-3 months Cytology Normal 3 years Cytology ASC-US/LSIL Immediately HPV Normal 3 years HPV-test HPV +ve 6-12 months HPV Normal and Cytology Normal/ASC-US 3 years HPV +ve Immediately New Cytology and HPVtest HPV Normal and LSIL or LSIL/AGUS/ ASC-H/ACIS/Ca Immediately Definitions ACIS: Adenocarcinoma in situ AGUS: Atypical glandular cells of undetermined significance, under cell. ASC-H: Irregular squamous cells with changes suggestive of high grade lesion, but do not meet all the criteria for diagnosis ASC-US: Irregular squamous cells with abnormalities of uncertain significance Ca: All types of cancer Cytology: Test to look at abnormal cells HPV: Humanpapillomavirus HSIL: High-grade squamous intraepithelial lesion LSIL: Low-grade squamous intraepithelial lesion 5
15 Triage Algorithm Invitation and Reminders Screening Exams 6
16 Triage Algorithm Invitation and Reminders Screening Exams 6
17 Verification and Validation Triage Algorithm Invitation and Reminders Screening Exams 6
18 Verification and Validation Triage Algorithm Invitation and Reminders Screening Exams 6
19 Verification and Validation Triage Algorithm Invitation and Reminders Screening Exams Statistics by epidemiologists 6
20 Verification and Validation Triage Algorithm Invitation and Reminders Screening Exams Statistics by epidemiologists Data exploration and visualization 6
21 7
22 What data? 8
23 9
24 What representation? 10
25 Querying 11
26 12
27 Portinari Flow Diagrams of Future Paths The flow diagram starts where the query patterns ends, showing Portinari allows two charts to be displayed side by side! Hovering over the edges or nodes of the graph shows stats! Each layer represents the distribution of diagnosis n exams into the future. 13
28 Explorations 14
29 Exploring effects of screening guidelines 3-4 years Cytology Normal Cytology Normal What happens after 3 years to this cohort? 15
30 Next Diagnosis in 3 years individuals 230,331 individuals 39 individuals 16
31 Next Two Diagnoses individuals individuals Did not return 17
32 Exploring existing screening guidelines 3-4 years Cytology Normal Cytology Normal What if women come back in the next 30 days? 18
33 4337 individuals Cytology not good enough for some? 19
34 Comparing two scenarios in the triage algorithm next exam Cytology Normal HPV +ve Come back within 1 year (Guideline) vs. Come back in 1 to 2 years 20
35 Returned within 1 year Returned in 1-2 years individuals 278 individuals (227) 1.61% HPV +ve (19) 6.83% HPV +ve 21
36 Conclusion Alternative way of verifying and validating paths taken by people in a socio-technical system. Use of easy-to-query graph database. Generalizable to event-driven data. Generation hypothesis for further statistical investigation. 22
37 Questions? Manoel Horta Ribeiro manoelribeiro homepages.dcc.ufmg.br/~manoelribeiro/ 23
38 Questions? Manoel Horta Ribeiro manoelribeiro homepages.dcc.ufmg.br/~manoelribeiro/ 23
Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationUnderstanding Your Pap Test Results
Understanding Your Pap Test Results Most laboratories in the United States use a standard set of terms called the Bethesda System to report pap test results. Normal: Pap samples that have no cell abnormalities
More informationBC Cancer Cervix Screening 2015 Program Results. February 2018
BC Cancer Cervix Screening 2015 Program Results BC Cancer Cervix Screening 2015 Program Results 2 Table of Contents BC Cancer Cervix Screening 2015 Program Results... 1 Table of Contents... 2 Program Overview...
More informationPortinari: A Data Exploration Tool to Personalize Cervical Cancer Screening
Portinari: A Data Exploration Tool to Personalize Cervical Cancer Screening arxiv:1704.00172v1 [cs.cy] 1 Apr 2017 Sagar Sen, Manoel Horta Ribeiro, Raquel C. de Melo Minardi, Wagner Meira Jr. and Mari Nygård
More informationColposcopy. Attila L Major, MD, PhD
Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000
More informationAppropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
More informationCervical Screening for Dysplasia and Cancer in Patients with HIV
Cervical Screening for Dysplasia and Cancer in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute w w w.hivg uidelines.org Purpose of the Guideline Increase
More informationEffect of human papillomavirus vaccination on cervical cancer screening in Alberta
Effect of human papillomavirus vaccination on cervical cancer screening in Alberta Presenter: Jong Kim 1 Team: Christopher Bell 2, Maggie Sun 3, Gordon Kliewer 3, Linan Xu 3, Maria McInerney 4, Lawrence
More informationScreening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA
Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA Cancer Care Ontario Cervical Cancer Screening Goals Increase patient participation in cervical screening Increase primary care
More informationChapter 10: Pap Test Results
Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the
More informationCERVICAL CANCER SCREENING SCENARIOS for pan-canadian Cervical Screening Initiative
CERVICAL CANCER SCREENING SCENARIOS for pan-canadian Cervical Screening Initiative June 18 2014 Acknowledgements Anthony Miller Cathy Popadiuk Claude Nadeau Keiko Asakawa Marc Brisson Michael Wolfson Saima
More informationMaking Sense of Cervical Cancer Screening
Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because
More informationEradicating Mortality from Cervical Cancer
Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus
More informationP16 et Ki67 Biomarkers: new tool for risk management and low grade intraepithelial lesions (LGSIL): be ready for the future.
P16 et Ki67 Biomarkers: new tool for risk management and low grade intraepithelial lesions (LGSIL): be ready for the future. Mark H Stoler, MD University of Virginia Health System, Charlottesville, VA,
More informationManagement Algorithms for Abnormal Cervical Cytology and Colposcopy
Management Algorithms for Abnormal Cervical Cytology and Colposcopy Table of Contents Standard Colposcopic Definitions... 1 Guidelines for the Assessment of Abnormal Cervical Cytology... 2 Ia: Persistent
More informationL impact attendu de la vaccination contre le virus du papillome humain sur les pratiques de dépistage du cancer du col uterin
10 es Journées annuelles de santé publique Palais des congrès de Montréal 23 au 27 octobre 2006 L impact attendu de la vaccination contre le virus du papillome humain sur les pratiques de dépistage du
More informationDepartment of Health Standard for the Cervical Cancer Screening Program. Approval Date: 08 May 2018 Effective Date: 13 May 2018
Document Title: Department of Health Standard for the Cervical Cancer Screening Program Document Ref. Number: DOH/CCSC/SD/1.0 Version: 1.0 Approval Date: 08 May 2018 Effective Date: 13 May 2018 Last Reviewed:
More informationASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests
ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests www.treatmentok.com Barbara S. Apgar, MD, MS Professor of Family Medicine University of Michigan Ann Arbor, Michigan Disclosures
More informationEuropean Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs
European Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs Introduction to the Survey The purpose of this project is to collect information regarding
More informationClinical Practice Guidelines June 2013
Clinical Practice Guidelines June 2013 General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method for the early
More informationCervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH
Cervical Testing and Results Management An Evidenced-Based Approach April 22nd, 2010 Debora Bear, MSN, MPH Assistant Medical Director for Planned Parenthood of New Mexico, Inc. Burden of cervical cancer
More informationDysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.
CLINICAL PRACTICE GUIDELINE Guideline Number: DHMP_DHMC_PG1015 Guideline Subject: Routine Cervical Cancer Screening Effective Date: 9/2018 Revision Date: 9/2019 Pages: 2 of 2 Quality Management Committee
More informationQA and Quality Indicators for Cervical Cancer Screening Programs. Guglielmo Ronco MD Senior Epidemiologist CPO Piemonte Turin, Italy
QA and Quality Indicators for Cervical Cancer Screening Programs Guglielmo Ronco MD Senior Epidemiologist CPO Piemonte Turin, Italy Disclosures No financial relationships or conflict of interest to disclose
More informationVideo Workshop Cervical cancer screening as a multidisciplinary process
Video Workshop Cervical cancer screening as a multidisciplinary process Dr. Amanda Herbert (Guy s & St Thomas NHS Foundation Trust, London) Professor Jaroslava Duskova (Charles University, Prague, Czech
More informationThe society for lower genital tract disorders since 1964.
The society for lower genital tract disorders since 1964. Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
More informationCervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely
More informationEVIDENCE REPORT. Ass.-Prof. Dr. Gaby Sroczynski, M.P.H., Univ.-Prof. Dr. Uwe Siebert, M.P.H., M.Sc.
EVIDENCE REPORT Decision Analysis for the Evaluation of Benefits, Harms and Cost-effectiveness of Different Cervical Cancer Screening Strategies to Inform the S3 Clinical Guideline Prevention of Cervical
More informationWhat is a Pap smear?
Pap smear What is a Pap smear? A Pap smear is a test that checks for changes in the cells of your cervix. The cervix is the lower part of the uterus that opens into the vagina. Developed over forty years
More information!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$
!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
More informationStreamlining Protocols-From Strategy to Implementation. Doreen Ramogola-Masire Botswana UPenn Partnership June 2014
Streamlining Protocols-From Strategy to Implementation Doreen Ramogola-Masire Botswana UPenn Partnership 18-20 June 2014 Botswana-UPenn Partnership Partnership between Government of Botswana, University
More informationUnderstanding My Pap Test Results
Form: D-8766 Understanding My Pap Test Results For patients of the Gynecology Oncology Clinic Read this pamphlet to learn more about: why you are having a Pap test how to understand your test results what
More informationFaculty Pap Smear Guidelines: Family Planning Update 2008 Part Two
Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health
More informationManitoba Cervical Cancer Screening Program. Operations & Statistical Report and 2006
anitoba Cervical Cancer Screening Program Operations & Statistical Report 2005 and 2006 1 MCCSP 2005-2006 Report ANITOBA CERVICAL CANCER SCREENING PROGRAM 2005 and 2006 Operations & Statistical Report
More informationLessons From Cases of Screened Women Who Developed Cervical Carcinoma
Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases
More informationGuidelines for Breast, Cervical and Colorectal Cancer Screening
Guidelines for Breast, Cervical and Colorectal Cancer Screening Your recommendation counts. Talk to your patients about screening for cancer. CancerCare Manitoba provides organized, population-based screening
More informationOver-diagnoses in Cytopathology: Is histology the gold standard?
Over-diagnoses in Cytopathology: Is histology the gold standard? Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Faculty Disclosures: Teresa M. Darragh,
More informationCervical Cancer 4/27/2016
Guidelines for Cervical Cancer Screening and Prevention Management of Abnormal Results Kathy A. King, MD Assistant Professor of OB/GYN Medical College of Wisconsin May 6, 2016 Cervical Cancer In US about
More informationICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way
ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING Central Valley Public Health: Women's Way ICD-9-CM (Top 35) ICD-10-CM ICD-10-CM Description COMMENTS V10.3: Personal history of malignant neoplasm of Z85.3
More informationImpact of psychosocial issues on cervical cancer prevention among Chinese women in Hong Kong
Impact of psychosocial issues on cervical cancer prevention among Chinese women in Hong Kong Annie NY CHEUNG MBBS, MD, PhD, FRCPath, FHKAM(Path), FIAC, IFCAP Laurence L T Hou Professorship in Anatomical
More informationHistopathology: Cervical HPV and neoplasia
Histopathology: Cervical HPV and neoplasia These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about
More informationANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION
Electronic Journal of Pharmacology and Therapy Vol 4, 15-20 (2011) ISSN: 0973-9890 (Available online at wwwtcrjournalscom) Clinical Article ndexed in: ProQuest database Abstract, USA (ProQuest Science
More informationCase Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure
Disclosure Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics This
More informationCuid d Fheidhmeannacht na Seirbhíse Sláinte. Part of the Health Service Executive. CS/PR/PM-20 Rev 2 ISBN Programme Report 2014/2015
Programme Report 2014/2015 Contents Summary points 2 Introduction to the statistics 2014/2015 3 Part 1 Cervical screening activity 3 Programme coverage 4 Laboratory turnaround time 7 Notification of results
More informationPopulation Effectiveness of HPV Vaccination on Cervical Cancer Prevention in the U.S. Project #3 Cosette M. Wheeler, Ph.D.
Population Effectiveness of HPV Vaccination on Cervical Cancer Prevention in the U.S. Project #3 Cosette M. Wheeler, Ph.D. - Leader Woman-based informatics program that captures all events and outcomes
More informationThese comments are an attempt to summarise the discussions at the manuscript meeting. They are not an exact transcript.
Dear dr. Weber, We would like to thank you for the review of our manuscript entitled Cervical screening with an interval beyond five years requires different rescreen times for HPV-negative and HPVpositive,
More informationClinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary
Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Glossary of Terms Colposcopy is the examination of the cervix, vagina and, in
More informationHuman Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted?
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Human Papillomaviruses
More informationCervical Dysplasia and HPV
Cervical Dysplasia and HPV J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse HPV Double stranded DNA virus The HPV infect epithelial cells of the skin and mucous membranes Highest risk
More informationEU guidelines for reporting gynaecological cytology
EU guidelines for reporting gynaecological cytology Amanda Herbert Guy s & St Thomas Foundation NHS Trust 5th EFCS Annual Tutorial, Trondheim, Norway 28 th May 1 st June 2012 EU guidelines aim to harmonize
More informationCervical Cancer Screening Update. Melissa Hartman, DO Women s Health
Cervical Cancer Screening Update Melissa Hartman, DO Women s Health Previous Cervical Cancer Screening Organization Recommendation ACS (2011) ACP (2008) NCI (2003) Age 21 or 3 years after first intercourse
More informationYour Colposcopy Visit
Introduction Welcome to the colposcopy clinic. This booklet tells you about. The colposcopy examination.. Tests that are done in the colposcopy clinic.. What these tests look for Take a few minutes to
More informationAtypical Glandular Cells of Undetermined Significance Outcome Predictions Based on Human Papillomavirus Testing
Anatomic Pathology / ATYPICAL GLANDULAR CELLS AND HUMAN PAPILLOMAVIRUS Atypical Glandular Cells of Undetermined Significance Outcome Predictions Based on Human Papillomavirus Testing Jeffrey F. Krane,
More informationI have no financial interests to disclose.
Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests
More informationHow invasive cervical cancer audit affects clinical practice
How invasive cervical cancer audit affects clinical practice Referring to NHSCSP and EU guidelines and audits in Southampton and London Amanda Herbert Guy s & St Thomas Foundation NHS Trust How invasive
More informationTECHNICAL APPENDIX HPV-ADVISE CDC
TECHNICAL APPENDIX HPV-ADVISE CDC Brisson, Marc Laprise, Jean-François Drolet, Mélanie Van de Velde, Nicolas Boily, Marie-Claude Marc Brisson, Nicolas Van de Velde, Marie-Claude Boily, 2014-2016. TECHNICAL
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Prevention: 2012 and Beyond George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics University of California,
More informationTriage of Women with Minor Cervical Lesions: Data Suggesting a Test and Treat Approach for HPV E6/E7 mrna Testing
Triage of Women with Minor Cervical Lesions: Data Suggesting a Test and Treat Approach for HPV E6/E7 mrna Testing Sveinung Wergeland Sørbye 1 *, Silje Fismen 1, Tore Gutteberg 2,3, Elin Synnøve Mortensen
More informationHPV TESTING AND THE RENEWAL PROGRAMME. Deborah Neesham Gynaecological Oncologist RWH
HPV TESTING AND THE RENEWAL PROGRAMME Deborah Neesham Gynaecological Oncologist RWH Statistics AIHW 2012 801 women were diagnosed with cervical cancer in 2011 and there were 226 deaths from cervical cancer
More informationHPV: cytology and molecular testing
HPV: cytology and molecular testing Human Papillomavirus and how we test for it at Medlab Central Palmerston North for Cervical Cancer prevention and management. Developed by Reem Mustafa Cytology and
More informationMultimodal Spectroscopic Imaging of the Cervix for Triaging Patients to Colposcopy
Multimodal Spectroscopic Imaging of the Cervix for Triaging Patients to Colposcopy L Twiggs, T De Santis, NM Chaktoura, D Ferris, L Flowers, M Lashgari, E Wilkinson, S Bambot, A Agrawal, and D Mongin EUROGIN
More informationHPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series
HPV and Cervical Cancer, Screening and Prevention John Ragsdale, MD July 12, 2018 CME Lecture Series We have come a long Way Prevalence HPV in Young Adults in U.S HPV genotypes 55-60% of All cancers 20%
More informationchapter 4. The effect of oncogenic HPV on transformation zone epithelium
chapter 4. The effect of oncogenic HPV on transformation zone epithelium CHAPTER 1 All squamous cervical cancer (and probably all cervical adenocarcinoma) is associated with oncogenic HPV, and the absence
More informationX-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers
X-Treme Primary Care: HPV and STIs Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers Learning Objectives Review recommendations for HPV related cancer screening in
More informationNo Disclosures. Updated Guidelines for Cervical Cancer Screening and Prevention Management of Abnormal Results. Objectives 5/9/2016
Updated Guidelines for Cervical Cancer Screening and Prevention Management of Abnormal Results Kathy A. King, MD Assistant Professor of OB/GYN Medical Director, PPWI Medical College of Wisconsin May 6,
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics
More informationDisclosures. Learning objectives. George F. Sawaya, MD. I have nothing to disclose.
Well Woman Visits in 2018: How Should We Approach Cervical Cancer Screening and Routine Pelvic Examinations? George F. Sawaya, MD Disclosures I have nothing to disclose. Professor, Obstetrics, Gynecology
More informationPushing the Boundaries of the Lab Diagnosis in Asia
Pushing the Boundaries of the Lab Diagnosis in Asia Diana Lim MBBS, FRCPA, FRCPath (UK) Senior Consultant National University Health System and National University of Singapore Department of Pathology
More informationManagement of Abnormal Cervical Cytology and Histology
Management of Abnormal Cervical Cytology and Histology Assoc. Prof. Gökhan Tulunay Etlik Zübeyde Hanım Women s Diseases Teaching & Research Hospital Gynecologic Oncology Clinic Universally accepted guideline
More informationSubmission from the Auckland Regional Public Health Service on the Proposed New Guidelines for the Management of Women with Abnormal Cervical Smears
Regional Public Health Service Cornwall Complex Floor 2, Building 15 Greenlane Clinical Centre Private Bag 92 605 Symonds Street New Zealand Telephone: 09-623 4600 Facsimile: 09-623 4633 6 December 2006
More informationBecoming a colposcopist: Colposcope case studies
Becoming a colposcopist: Colposcope case studies Seon-Kyung Lee, M.D. Department of Obstetrics and Gynecology College of Medicine, Kyung Hee University Value of Colposcopy Cytology is an effective screening
More informationNational Cervical Screening Program MBS Item Descriptors
National Cervical Screening Program MBS Item Descriptors Item Item descriptor 73070 A test, including partial genotyping, for oncogenic human papillomavirus that may be associated with cervical pre-cancer
More informationWhat is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Harris Health System
What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Manager @ Harris Health System What is a Pap Smear and when is it recommended? Pap smear The Pap smear is a screening
More informationThe new Cervical Screening Test for Australian women: Louise Farrell
The new Cervical Screening Test for Australian women: Louise Farrell Outline and explain the changes to the National Cervical Screening Program due to commence in Dec 2017 LEARNING OBJECTIVES FOR TODAY
More informationShould Anal Pap Smears Be a Standard of Care in HIV Management?
Should Anal Pap Smears Be a Standard of Care in HIV Management? Gordon Dickinson, M.D., FACP Professor of Medicine and Chief Infectious Diseases, Miller School of Medicine Short Answer: NO But 15-20 HPV
More informationCAP Laboratory Improvement Programs
CAP Laboratory Improvement Programs Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology, 2006 Galen M. Eversole, MD; Ann T. Moriarty,
More informationKing s Research Portal
King s Research Portal DOI: 10.1111/cyt.12259 Document Version Publisher's PDF, also known as Version of record Link to publication record in King's Research Portal Citation for published version (APA):
More informationHPV Genotyping: A New Dimension in Cervical Cancer Screening Tests
HPV Genotyping: A New Dimension in Cervical Cancer Screening Tests Lee P. Shulman MD The Anna Ross Lapham Professor in Obstetrics and Gynecology and Chief, Division of Clinical Genetics Feinberg School
More informationHPV & CERVICAL CANCER POLICY & LEGISLATIVE TOOLKIT, 3 RD EDITION
HPV Vaccine FAST FACTS: Payer & Reimbursement Strategies Medicaid: Many state Medicaid programs cover the HPV vaccine, though this coverage varies by state. Information on coverage can be found through
More informationName of Policy: Speculoscopy
Name of Policy: Speculoscopy Policy #: 095 Latest Review Date: September 2011 Category: Medicine/OB Gyn Policy Grade: C Background/Definitions: As a general rule, benefits are payable under Blue Cross
More informationCervical Cancer Prevention in the 21 st Century Changing Paradigms
Cervical Cancer Prevention in the 21 st Century Changing Paradigms Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Faculty Disclosures: Teresa M.
More informationSamuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida
Making sense of the new Pap smear screening guidelines. Samuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida Case 17 year old G1P0010 with first sexual encounter
More informationBiomed Environ Sci, 2015; 28(1): 80-84
80 Biomed Environ Sci, 2015; 28(1): 80-84 Letter to the Editor Assessing the Effectiveness of a Cervical Cancer Screening Program in a Hospital-based Study* YANG Yi1, LANG Jing He1, WANG You Fang1, CHENG
More informationProtocol for an integrated data request of test results from the laboratories of pathological anatomy
Protocol for an integrated data request of test results from the laboratories of pathological anatomy Cancer diagnoses & early detection of cancer (breast, colorectal and cervix) CODAP page 1 Table of
More informationCervical Cancer Screening. David Quinlan December 2013
Cervical Cancer Screening David Quinlan December 2013 Cervix Cervical Cancer Screening Modest variation provincially WHO and UK begin at 25 stop at 60 Finland begin at 30 stop at 60 Rationale for
More informationCervical Screening Recommendation for non HIV-infected Immunosuppressed Women
Cervical Screening Recommendation for non HIV-infected Immunosuppressed Women Chair: Anna-Barbara Moscicki Team (in alphabetic order): Lisa Flowers, Michael Gold, Megan Huchko, Margaret Long, Kathy MacLaughlin,
More informationCINtec PLUS and the Pap smear: a co-testing alternative
CINtec PLUS and the Pap smear: a co-testing alternative Rosemary Tambouret MD p16/ki67 (CINtec PLUS) and the Pap smear Rosemary Tambouret MD CINtec PLUS dual stain: p16 and Ki67 p16 is anti-proliferative
More informationObjectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies
Cervical Cancer Screening Guidelines: Updates and Controversies I have no financial interests in any product I will discuss today. Jody Steinauer, MD, MAS University of California, San Francisco Objectives
More informationQuantitative Optical Spectroscopy of the Uterine Cervix: A cost effective way to detect and manage cervical disease
Quantitative Optical Spectroscopy of the Uterine Cervix: A cost effective way to detect and manage cervical disease Nahida Chakhtoura, MD, Leo Twiggs, MD, Timothy DeSantis, MD Claudia Werner, MD, William
More informationStandards for Pathology Informatics in Australia (SPIA)
Standards for Pathology Informatics in Australia (SPIA) Reporting Terminology and Codes Cytopathology (v3.0) Superseding and incorporating the Australian Pathology Units and Terminology Standards and Guidelines
More informationSOGC / SCC Clinical Practice Guideline
SOGC / SCC Clinical Practice Guideline Colposcopic Management of Abnormal Cervical Cancer Screening and Histology These Clinical Practice Guidelines have been prepared and approved by the Executive and
More informationGYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital
GYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital and Bioreference Labs (Houston) Department of Pathology
More informationHPV Knowledge Survey Healthcare Providers
1. What is your age? m 20-24 m 25-35 m 36-45 m 46-55 m 56-65 m 66-75 2. What is your gender? m Male m Female m Other 3. Which ethnic group do you identify with (please tick all that apply)? m New Zealand
More information2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license
Cost-effective management of women with minor cervical lesions: Revisiting the application of HPV DNA testing. Pedersen K, Burger EA, Sy S, Kristiansen IS, Kim JJ. Gynecol Oncol. 2016 Aug 16. 2016. This
More informationResults of delayed triage by HPV testing and cytology in the Norwegian Cervical Cancer Screening Programme
Acta Oncologica ISSN: 0284-186X (Print) 1651-226X (Online) Journal homepage: http://www.tandfonline.com/loi/ionc20 Results of delayed triage by HPV testing and cytology in the Norwegian Cervical Cancer
More informationScreening for the Precursors of Cervical Cancer in the Era of HPV Vaccination. Dr Stella Heley Senior Liaison Physician Victorian Cytology Service
Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination Dr Stella Heley Senior Liaison Physician Victorian Cytology Service Victorian Cytology Service Dr Stella Heley Dr Siobhan Bourke
More informationANNUAL REVIEW 2017 SUMMARY
CERVICAL CANCER SCREENING PROGRAMME IN FINLAND ANNUAL REVIEW 2017 There are regional differences in the nationwide Finnish organised screening programme for cervical cancer. To unify the programme the
More informationRESULTS OF BREAST AND CERVICAL CANCERS SCREENING IN HAIPHONG WITHIN 5 YEARS FROM 2011 TO Hoa Nguyen Lam, Huyen Suong Ho Thi et al.
RESULTS OF BREAST AND CERVICAL CANCERS SCREENING IN HAIPHONG WITHIN 5 YEARS FROM 2011 TO 2015 Hoa Nguyen Lam, Huyen Suong Ho Thi et al. INTRODUCTION BREAST CANCER The most common malignancy in Vietnam-women
More informationGUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED
GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED This guideline is a revised version of the guideline developed in February 2000, by the Cervical Cancer Screening Working Group. This revised version
More informationNew Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology
New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology United States and Canadian Academy of Pathology 102 nd Annual Meeting Baltimore, Maryland Christina S. Kong, M.D.
More information